Nissen E D, Kent D R, Nissen S E
Am J Obstet Gynecol. 1977 Jan 1;127(1):61-6. doi: 10.1016/0002-9378(77)90315-5.
Within the last several years, previously rare liver tumors have been seen in young women using oral contraceptive steroids. The Registry for Liver Tumors Associated with Oral Contraceptives at the University of California, Irvine, has clearly identified 27 cases. The recent literature contains 44 case reports. Common to these 71 cases has been a histopathologic diagnosis of focal nodular hyperplasia, adenoma, hamartoma, and hepatoma. Significant statistical etiologic factors include prolonged uninterrupted usage of oral contraceptive steroids. Eight deaths and liver rupture in 18 patients attest to the seriousness of this new potentially lethal adverse phenomenon.
在过去几年里,服用口服避孕甾体激素的年轻女性中出现了以前罕见的肝脏肿瘤。加利福尼亚大学欧文分校的口服避孕药相关肝脏肿瘤登记处已明确确认了27例病例。近期文献中有44例病例报告。这71例病例的共同之处在于组织病理学诊断为局灶性结节性增生、腺瘤、错构瘤和肝癌。重要的统计学病因因素包括长期不间断使用口服避孕甾体激素。18名患者中有8例死亡和肝脏破裂,证明了这种新的潜在致命不良现象的严重性。